Overview

Comparison of Three Combination Chemotherapy Regimens in Treating Women With Stage I or Stage II Breast Cancer

Status:
Completed
Trial end date:
2005-09-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: This randomized phase II trial is studying three regimens of combination chemotherapy to compare how well they work in treating women with stage I or stage II breast cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Royal Marsden NHS Foundation Trust
Treatments:
Cyclophosphamide
Doxorubicin
Epirubicin
Liposomal doxorubicin
Mitoxantrone
Vinorelbine